Press release
Addii Biotech Unveils Beta Lactam Antibiotics Manufacturing Unit: Expanding Opportunities in the Healthcare Industry
Addii Biotech Unveils Beta Lactam Antibiotics Manufacturing Unit
Beta Lactam antibiotics are crucial in the fight against bacterial infections, forming the backbone of many healthcare regimens worldwide. By launching this specialized manufacturing unit, Addii Biotech not only strengthens its position as a trusted pharmaceutical partner but also reaffirms its commitment to delivering quality and affordability in healthcare solutions.
A Commitment to Excellence
The new manufacturing unit is built on the principles of innovation, safety, and sustainability. It adheres to stringent WHO-GMP-certified processes, ensuring that every product meets global quality standards.
"This launch marks a significant milestone in our journey to redefine healthcare standards," said Lalit Dogra, Managing Director, Addii Biotech. The facility operates under globally recognized standards, ensuring the highest levels of product safety and efficacy.
Redefining Healthcare with Collaboration
Addii Biotech's mission extends beyond manufacturing; the company actively seeks partnerships with pharmaceutical businesses through third-party manufacturing services. This initiative provides businesses with the opportunity to leverage Addii Biotech's advanced infrastructure and expertise to bring their own visions to life.
A Global Vision for Better Healthcare
The launch of the Beta Lactam Antibiotics Manufacturing Unit aligns with Addii Biotech's vision of creating a healthier world through accessible and reliable pharmaceutical solutions. By addressing critical healthcare needs with precision and care, the company strives to make a tangible impact on patient lives globally.
Addii Biotech Pvt. Ltd.
Address: Village Kaundi, Post Office Thana, Tehsil Baddi, Distt Solan, Himachal Pardesh-173205
Phone: +91 79000-21919
Website: https://www.addiibiotech.com
Addii Biotech is India's fastest growing pharmaceutical company renowned for its commitment to quality, excellence and innovation. With a diverse portfolio of high-quality products and WHO-GMP-certified facilities, the company serves healthcare needs across the globe, fostering a vision of better healthcare for all.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Addii Biotech Unveils Beta Lactam Antibiotics Manufacturing Unit: Expanding Opportunities in the Healthcare Industry here
News-ID: 3786247 • Views: …
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
